TITLE

The Effect of Osteoclastic Activity on Tendon-to-Bone Healing: An Experimental Study in Rabbits

AUTHOR(S)
Rodeo, Scott A.; Kawamura, Sumito; Ma, C. Benjamin; Xiang-hua Deng; Sussman, Patrick S.; Hays, Peyton; Liang Ying
PUB. DATE
October 2007
SOURCE
Journal of Bone & Joint Surgery, American Volume;Oct2007, Vol. 89-A Issue 10, p2250
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Healing of a tendon graft in a bone tunnel depends on bone ingrowth into the interface between tendon and bone. Excessive osteoclastic activity may contribute to bone resorption, tunnel widening, and impaired healing. We hypothesized that inhibition of osteoclastic activity by osteoprotegerin (OPG) would increase bone formation around a tendon graft in anterior cruciate ligament reconstruction in a rabbit model, while increased osteoclastic activity due to the aplication of receptor activator of nuclear factor-kappa B ligand (RANKL) would impair bone ingrowth. Methods: Sixty skeletally mature, male New Zealand White rabbits underwent bilateral anterior cruciate ligament reconstruction. OPG (100 μg per tunnel) or RANKL (10 μg per tunnel) was delivered to the tendon-bone interface with use of a synthetic calcium phosphate carrier vehicle. Twenty animals were killed at two, four, and eight weeks after surgery. Two rabbits from each group were prepared for histological evaluation, and the other rabbits were used for biomechanical testing. Results: A significantly greater amount of bone surrounded the tendon at the healing tendon-bone interface in the OPG-treated limbs compared with the controls and the RANKL-treated limbs at all time-points (p < 0.05). There were significantly fewer osteoclasts in the OPG-treated limbs compared with the controls and the RANKL-treated limbs (p < 0.05). The average tunnel area in the OPG group was significantly smaller than that in the RANKL group (p = 0.003 at two weeks and p = 0.004 at four weeks). The femur-anterior cruciate ligament-tibia complex of the OPG-treated limbs had significantly increased stiffness compared with RANKL-treated limbs at eight weeks (p = 0.04). Conclusions: Osteoprotegerin significantly improves bone formation around the grafted tendon and improves the stiffness at the healing tendon-bone junction in a rabbit model. Clinical Relevance: Inhibition of excessive osteoclastic activity may improve tendon-to-bone healing.
ACCESSION #
27094002

 

Related Articles

  • Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation. Yamaguchi, Masayoshi; Weitzmann, M. // Molecular & Cellular Biochemistry;Sep2011, Vol. 355 Issue 1/2, p179 

    Zinc is essential for numerous biochemical pathways in the body and is known to significantly affect the skeleton. Zinc has a profound effect on bone turnover promoting bone formation and mineralization, but paradoxically inhibiting osteoclastic bone breakdown (resorption). How zinc regulates...

  • Bone-Resorbing Cells in Multiple Myeloma: Osteoclasts, Myeloma Cell Polykaryons, or Both? SILVESTRIS, FRANCO; CIAVARELLA, SABINO; DE MATTEO, MONICA; TUCCI, MARCO; DAMMACCO, FRANCO // Oncologist;Mar2009, Vol. 14 Issue 3, p264 

    Myeloma bone disease (MBD) leads to progressive destruction of the skeleton and is the most severe cause of morbidity in multiple myeloma. Its pathogenetic mechanisms are not fully understood, though the current evidence points to osteoclast (OC) hyperactivity coupled with defective osteoblast...

  • Novel Anti-Cancer Strategy in Bone Tumors by Targeting Molecular and Cellular Modulators of Bone Resorption. B�n�dicte, Brounais; Carmen, Ruiz V.; Julie, Rousseau; Fran�ois, Lamoureux; Fr�d�ric, Blanchard; Dominique, Heymann; Fran�oise, Redini // Recent Patents on Anti-Cancer Drug Discovery;Nov2008, Vol. 3 Issue 3, p178 

    Tumor cells alter the balanced process of bone formation and bone resorption mediated respectively by osteoblasts and osteoclasts, leading to the disruption of the normal equilibrium and resulting in a spectrum of osteolytic to osteoblastic lesions. This review will summarize research on...

  • Macrophages that have phagocytosed particles are capable of differentiating into functional osteoclasts. Fujikawa, Yosuke; Itonaga, Ichiro; Kudo, Osami; Hirayama, Takahisa; Taira, Hirofumi // Modern Rheumatology (Springer Science & Business Media B.V.);Oct2005, Vol. 15 Issue 5, p346 

    The aim of the current study was to determine whether human macrophages that have phagocytosed particles are capable of differentiating into osteoclastic bone-resorbing cells. Macrophages isolated from human peripheral blood were cultured with latex particles in the presence of receptor...

  • Establishment of a new murine model of hypercalcemia with anorexia by overexpression of soluble receptor activator of NF-κB ligand using an adenovirus vector. Enomoto, Tetsuro; Furuya, Yuriko; Tomimori, Yoshiya; Mori, Kaoru; Miyazaki, Jun-ichi; Yasuda, Hisataka // Journal of Bone & Mineral Metabolism;Jul2011, Vol. 29 Issue 4, p414 

    Hypercalcemia is a significant complication of certain human malignancies that is primarily caused by the release of calcium from bone due to marked bone resorption by osteoclast activation. Osteoclast differentiation and activation is mediated by receptor activator of NF-κB ligand (RANKL)....

  • Dynamic visualization of RANKL and Th17-mediated osteoclast function. Kikuta, Junichi; Wada, Yoh; Kowada, Toshiyuki; Ze Wang; Sun-Wada, Ge-Hong; Nishiyama, Issei; Mizukami, Shin; Maiya, Nobuhiko; Yasuda, Hisataka; Kumanogoh, Atsushi; Kikuchi, Kazuya; Germain, Ronald N.; Ishii, Masaru // Journal of Clinical Investigation;Feb2013, Vol. 123 Issue 2, p866 

    Osteoclasts are bone resorbing, multinucleate cells that differentiate from mononuclear macrophage/monocyte- lineage hematopoietic precursor cells. Although previous studies have revealed important molecular signals, how the bone resorptive functions of such cells are controlled in vivo remains...

  • MIP-1δ Activates NFATc1 and Enhances Osteoclastogenesis: Involvement of Both PLCγ2 and NFκB Signaling. Weber, Kristy L.; Doucet, Michele; Shaner, Adam; Hsu, Nigel; Huang, David; Fogel, Jenna; Kominsky, Scott L. // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Pathological bone resorption is a source of significant morbidity in diseases affecting the skeleton such as rheumatoid arthritis, periodontitis, and cancer metastasis to bone. Evidence indicates that elevated levels of inflammatory mediators such as IL-1, IL-6, and TNF-α play a role in this...

  • Retinoic acid inhibits NFATc1 expression and osteoclast differentiation. Balkan, Wayne; Rodríguez-Gonzalez, María; Pang, Manhui; Fernandez, Isabel; Troen, Bruce // Journal of Bone & Mineral Metabolism;Nov2011, Vol. 29 Issue 6, p652 

    Ingestion of excess vitamin A appears to correlate with an increased fracture risk, an outcome that is likely mediated by retinoic acids (RAs); these are vitamin A metabolites that have dramatic effects on skeletal development. We studied the impacts of RA and isoform-specific RA receptor (RAR)...

  • High level secretory expression of murine OCIL by CHO cells and action of OCIL on osteoclast differentiation. Cui, Zhuang; Mi, Meng; Wang, Jun; Liang, Hui; Zheng, Fang; Wang, Bao-Li; Li, Xiao-Xia // Molecular Biology;Aug2011, Vol. 45 Issue 4, p686 

    Receptor activator of nuclear factor-kB ligand (RANKL), a well-known membrane-bound molecule expressed on osteoblasts and bone marrow stromal cells, is believed to induce osteoclast differentiation and activation by binding to the receptor activator of nuclear factor-kB (RANK), which is...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics